Core Viewpoint - The company, CanSino, is focusing on its main business while leveraging its mRNA technology platform to explore additional application areas and potential commercial opportunities [1] Group 1 - CanSino plans to utilize its mRNA technology platform to expand into more application fields [1] - The company is committed to sharing updates on any significant progress made in this area [1]

Core Viewpoint - The company, CanSino, is focusing on its core business while exploring additional indications in the treatment field using its mRNA technology platform, with updates to be provided upon significant progress [1]. Group 1 - CanSino is committed to enhancing its main business operations [1]. - The company is leveraging its mRNA technology platform for further exploration in treatment indications [1]. - CanSino will announce any significant advancements in its research and development efforts in a timely manner [1].